The percentage of IL‐17‐producing CD4+ and CD8+ T-cells positive for TLR2 was also significantly higher in the cultures from MDD MS patients, which corresponds to increasing IL-17 production by activated PBMCs in MDD MS patients. This evidence concerns the gene CD4 and myeloid sarcoma.